仁度生物 (688193.sh)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(仁度生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度销售毛利率(%) 81.0081.0082.0082.0080.0051.0073.0067.0069.00
 单季度销售净利率(%) 8.0035.005.00-9.00-16.00-1.003.007.0018.00
 单季度净资产收益率ROE(%) -2.00---1.00--1.003.00
 单季度总资产净利率ROA(%) -2.00---1.00---2.00
单季度财务摘要:
 单季度营业总收入(元) 44,815,148.0047,313,965.0037,068,338.0041,263,469.0038,766,500.0063,752,996.0070,433,694.0076,381,830.0093,280,166.00
 单季度营业总成本(元) 43,739,945.0047,481,839.0037,569,754.0048,877,572.0048,358,348.0069,561,807.0073,704,337.0074,008,661.0073,195,655.00
 单季度营业收入(元) 44,815,148.0047,313,965.0037,068,338.0041,263,469.0038,766,500.0063,752,996.0070,433,694.0076,381,830.0093,280,166.00
 单季度营业利润(元) 3,373,724.0016,726,413.001,534,178.00-4,642,482.00-8,175,896.00-3,133,241.004,789,682.005,791,027.0020,059,671.00
 单季度利润总额(元) 3,373,142.0016,542,108.001,189,069.00-4,644,537.00-8,324,108.00-3,135,226.004,264,753.005,486,966.0020,065,023.00
 单季度净利润(元) 3,703,908.0016,602,525.001,849,405.00-3,800,298.00-6,392,336.00-423,305.001,833,063.005,115,001.0016,806,635.00
 单季度归属母公司股东的净利润(元) 3,703,908.0016,602,525.001,849,405.00-3,800,298.00-6,392,336.00-423,305.001,833,063.005,115,001.0016,806,635.00
 单季度经营活动产生的现金流量(元) 8,135,230.0029,210,485.001,928,682.00-7,734,018.00-6,213,384.0011,340,695.00-10,135,208.00-11,257,959.005,961,280.00
 单季度投资活动产生的现金流量(元) -15,640,941.00-96,473,275.00391,440,949.0025,586,808.00-18,630,363.00-430,706,444.00-109,649,476.002,144,097.00-3,466,731.00
 单季度筹资活动产生的现金流量(元) -12,233,123.00-1,397,640.00-1,208,475.00-5,356,418.00-1,003,627.00-4,378,707.00-2,708,157.00-20,805,769.00675,181,222.00
 单季度现金及现金等价物净增加(元) -19,657,841.00-72,260,198.00392,926,688.0015,663,465.00-25,697,122.00-425,359,311.00-121,903,543.00-29,159,428.00677,788,032.00

前瞻产业研究院